Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Top Cited Papers
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 97, 396-403
- https://doi.org/10.1016/j.ijid.2020.06.099
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- COVID-19—New Insights on a Rapidly Changing EpidemicJAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization processThe Journal of Antibiotics, 2019
- A Modified Sequential Organ Failure Assessment Score for Critical Care TriageDisaster Medicine and Public Health Preparedness, 2010
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosusArthritis & Rheumatism, 2010
- Effects of chloroquine on viral infections: an old drug against today's diseasesThe Lancet Infectious Diseases, 2003